Identifying and Addressing Social Determinants of Health to Reduce the National Burden of and Inequities in Dementia
识别和解决健康的社会决定因素,以减轻痴呆症的国家负担和不平等现象
基本信息
- 批准号:10597433
- 负责人:
- 金额:$ 238.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-01-01 至 2025-12-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdjusted Life YearsAdultAffectAgeAll of Us Research ProgramAlzheimer&aposs disease related dementiaAlzheimer&aposs disease riskAmericanAreaBiological MarkersCause of DeathCessation of lifeCognitiveCommunitiesCost SavingsDNA MethylationDataDatabasesDementiaDiagnosisDisparityEconomicsEducationElderlyElectronic Health RecordEpidemiologyEthnic OriginFutureGenderGoalsHealthHealth and Retirement StudyHospitalsHypertensionImpaired cognitionIncidenceInequityKnowledgeLeftLengthLife ExpectancyLinkLongitudinal StudiesMachine LearningMeasuresMediationMedicare claimMemoryMemory LossMental DepressionMental disordersModelingOutpatientsParticipantPathway interactionsPoliciesPolicy MakerPopulationPrevention ResearchProductivityPublic PolicyQuality-Adjusted Life YearsQuasi-experimentRaceRiskRisk FactorsShapesSocial MobilitySocial SecuritySocioeconomic StatusTaxesTestingTranslatingUnited StatesUnited States National Institutes of HealthVulnerable PopulationsWagesWomancomparativecostdevelopment policyeconomic impactethnic minority populationevidence basehealth datahealth disparity populationsimprovedinnovationlongitudinal datasetmiddle agemodels and simulationmortalitymortality disparitymulti-ethnicnovelphysical conditioningpopulation healthpredictive modelingprotective factorspublic health relevanceracial minority populationresponserisk mitigationsocialsocial determinantssocial health determinantstelomeretooltranslational impact
项目摘要
PROJECT SUMMARY/ABSTRACT
Alzheimer’s disease and related dementias (ADRD) are an escalating national crisis that shapes overall levels
of population health including average life expectancy. Critically, in order to effectively address this crisis, it is
imperative that we identify its root causes, which may include social determinants of health (SDoH) such as
education spending and social mobility, and that we modify these root causes through corresponding policies.
While a handful of SDoH have been shown to predict cognitive decline and ADRD, important questions remain
about which SDoH are root social drivers i.e., have the greatest impacts. Despite increasing calls for
comparative assessments to unpack and address the root causes—the social determinants—of ADRD, we lack
knowledge on the relative ADRD burden and economic impacts associated with modifying SDoH, including
policies such as the social security benefits tax. Furthermore, we have yet to establish which subpopulations
are most affected by SDoH. Given this information, there are critical needs to accurately estimate SDoH impacts,
including by subpopulation; and to translate these estimates into priority-setting tools including impacts on ADRD
burden and costs. Left unaddressed, these critical needs will hinder the development of policies to more
effectively reduce ADRD burden and inequities. Our overall objective is to use large multilevel, longitudinal
datasets and quasi-experimental approaches to construct the first comparative assessment evidence
base on the social drivers of ADRD burden and inequities. We will accomplish our overall objective by pursuing
the following specific aims using data in adults age 50+ from: the nationally-representative Mortality Disparities
in American Communities Study, linked to national mortality databases; the nationally-representative Health and
Retirement Study, linked to Medicare claims data; and the NIH’s All of Us Program, a multiethnic study linked to
electronic health records (EHR) data on diagnoses/treatments of health conditions: Aim 1) To assess the
impacts of area-level SDoH including state policies as protective factors against ADRD mortality, that
may vary across health disparity populations; Aim 2) To evaluate the impacts of area-level SDoH on
memory decline in middle-aged adults and incidence of cognitive impairment and dementia in older
adults; Aim 3) To explore the mechanisms through which area-level SDoH may protect against ADRD
incidence and cognitive impairment/decline, including physical/mental health disorders and biomarkers;
and Aim 4) To ascertain which area-level SDoH, if modified, are expected to yield the greatest reductions
in levels of and inequities in ADRD burden and costs. Regarding impact, we will identify the most promising
SDoH on which to intervene to yield improvements in ADRD burden and inequities. We will further establish the
pathways to differential vulnerabilities by subpopulation. By translating estimates into population health metrics,
we anticipate our project will have high translational impact through guiding policymakers' evidence-based
decisions about policies to more effectively reduce the burden of and inequities in ADRD among Americans.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Daniel Kim其他文献
Daniel Kim的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Daniel Kim', 18)}}的其他基金
Quantitative Detection of Coronary Microvascular Dysfunction in Long COVID Patients using a Comprehensive, Rapid, Free-Breathing Cardiovascular MRI
使用全面、快速、自由呼吸的心血管 MRI 定量检测长期新冠肺炎患者的冠状动脉微血管功能障碍
- 批准号:
10671235 - 财政年份:2023
- 资助金额:
$ 238.05万 - 项目类别:
Comparative Assessment of Modifying Social Determinants of Health to Reduce Firearm-Related Mortality and Disparities
修改健康社会决定因素以减少枪支相关死亡率和差异的比较评估
- 批准号:
10322069 - 财政年份:2021
- 资助金额:
$ 238.05万 - 项目类别:
Real-time Wideband Cardiac MRI for Patients with a Cardiac Implantable Electronic Device
针对心脏植入电子设备患者的实时宽带心脏 MRI
- 批准号:
10544094 - 财政年份:2020
- 资助金额:
$ 238.05万 - 项目类别:
Real-time Wideband Cardiac MRI for Patients with a Cardiac Implantable Electronic Device
针对心脏植入电子设备患者的实时宽带心脏 MRI
- 批准号:
10327327 - 财政年份:2020
- 资助金额:
$ 238.05万 - 项目类别:
Real-time Wideband Cardiac MRI for Patients with a Cardiac Implantable Electronic Device
针对心脏植入电子设备患者的实时宽带心脏 MRI
- 批准号:
9912936 - 财政年份:2020
- 资助金额:
$ 238.05万 - 项目类别:
Diversity Supplement for Real-time Wideband Cardiac MRI for Patients with a Cardiac Implantable Electronic Device
为心脏植入电子设备患者提供实时宽带心脏 MRI 的多样性补充
- 批准号:
10478468 - 财政年份:2020
- 资助金额:
$ 238.05万 - 项目类别:
Real-time Wideband Cardiac MRI for Patients with a Cardiac Implantable Electronic Device
针对心脏植入电子设备患者的实时宽带心脏 MRI
- 批准号:
10756060 - 财政年份:2020
- 资助金额:
$ 238.05万 - 项目类别:
Rapid Pediatric Cardiovascular MRI without Contrast Agent or Anesthesia
无需造影剂或麻醉的快速儿童心血管 MRI
- 批准号:
9308233 - 财政年份:2017
- 资助金额:
$ 238.05万 - 项目类别:
Rapid Real-Time Cardiovascular MRI for Detecting Coronary Artery Disease
用于检测冠状动脉疾病的快速实时心血管 MRI
- 批准号:
9753768 - 财政年份:2017
- 资助金额:
$ 238.05万 - 项目类别:
Comparative Assessment of Modifying Social Determinants to Reduce Cardiovascular Disease Burden and Disparities
修改社会决定因素以减少心血管疾病负担和差异的比较评估
- 批准号:
9368192 - 财政年份:2017
- 资助金额:
$ 238.05万 - 项目类别:
相似海外基金
Impact of ANCA Type and Rituximab vs. Cyclophosphamide on Cardiovascular Risk, Mortality, and Quality-Adjusted Life Years inANCA-Associated Vasculitis
ANCA 类型和利妥昔单抗与环磷酰胺对 ANCA 相关性血管炎的心血管风险、死亡率和质量调整生命年的影响
- 批准号:
10292270 - 财政年份:2021
- 资助金额:
$ 238.05万 - 项目类别:
Estimation of Quality-Adjusted Life Years via Joint Longitudinal-Survival Modelling
通过联合纵向生存模型估计质量调整生命年
- 批准号:
2203100 - 财政年份:2019
- 资助金额:
$ 238.05万 - 项目类别:
Studentship
Impact of ANCA Type and Rituximab vs. Cyclophosphamide on Cardiovascular Risk, Mortality, and Quality-Adjusted Life Years inANCA-Associated Vasculitis
ANCA 类型和利妥昔单抗与环磷酰胺对 ANCA 相关性血管炎的心血管风险、死亡率和质量调整生命年的影响
- 批准号:
9886161 - 财政年份:2018
- 资助金额:
$ 238.05万 - 项目类别:
Impact of ANCA Type and Rituximab vs. Cyclophosphamide on Cardiovascular Risk, Mortality, and Quality-Adjusted Life Years inANCA-Associated Vasculitis
ANCA 类型和利妥昔单抗与环磷酰胺对 ANCA 相关性血管炎的心血管风险、死亡率和质量调整生命年的影响
- 批准号:
10372989 - 财政年份:2018
- 资助金额:
$ 238.05万 - 项目类别:
Quality of life and Qualtiy-Adjusted Life Years in breast cancer patients receiving postoperative adjuvant chemotherapy
接受术后辅助化疗的乳腺癌患者的生活质量和质量调整生命年
- 批准号:
24701038 - 财政年份:2012
- 资助金额:
$ 238.05万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Measuring quality adjusted life years in children with autism spectrum disorders
测量自闭症谱系障碍儿童的质量调整生命年
- 批准号:
8061015 - 财政年份:2010
- 资助金额:
$ 238.05万 - 项目类别:
Measuring quality adjusted life years in children with autism spectrum disorders
测量自闭症谱系障碍儿童的质量调整生命年
- 批准号:
7937946 - 财政年份:2009
- 资助金额:
$ 238.05万 - 项目类别:
Measuring quality adjusted life years in children with autism spectrum disorders
测量自闭症谱系障碍儿童的质量调整生命年
- 批准号:
7844242 - 财政年份:2009
- 资助金额:
$ 238.05万 - 项目类别:
NIAAA-07-06 - Disability-adjusted Life Years
NIAAA-07-06 - 伤残调整生命年
- 批准号:
7544017 - 财政年份:2007
- 资助金额:
$ 238.05万 - 项目类别: